Nerf is making a $170 gun based on a League of Legends rocket launcher

Ireland News News

Nerf is making a $170 gun based on a League of Legends rocket launcher
Ireland Latest News,Ireland Headlines
  • 📰 pcgamer
  • ⏱ Reading Time:
  • 40 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 67%

Jinx's famous Fishbones is coming to Nerf.

, until January 3, 2023, but isn't currently slated to ship until December 1, 023—just in time for the next holiday season. Predictably, this bad boy isn't cheap: It goes for $170, which according to themakes it the most expensive Nerf LMTD weapon on the market, well ahead of the Star Wars: The Mandalorian Amban Phase-Pulse Blaster , the Star Trek: Starfleet Type 3 and Type 2 Phaser Blasters , the Star Wars: Boba Fett EE-3 Blaster , and Halo Needler .

Amazingly, that hefty price tag doesn't even include any extra darts—it comes with just 18, a single loadout—although it does have a"Jinx-inspired display stand and premium packaging," presumably because nobody who buys one of these things is ever actually going to take it outside and play with it. I'm not sure I'd ever spend that kind of coin on a Nerf gun, and especially one that my nephew is going to break the first time he comes over anyway. But it is a pretty sweet-looking piece of kit—I imagine that the Nerf/LoL crossover fandom is going to have a hard time not pulling the trigger on this one.Andy has been gaming on PCs from the very beginning, starting as a youngster with text adventures and primitive action games on a cassette-based TRS80.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

pcgamer /  🏆 38. in UK

Ireland Latest News, Ireland Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

'Heartbroken' Glasgow-based vegan online supermarket closes'Heartbroken' Glasgow-based vegan online supermarket closesA popular vegan online supermarket has announced closure.
Read more »

Made.com stock to be sold by Nottingham based auctioneerMade.com stock to be sold by Nottingham based auctioneerThousands of upholstery, home furniture, outdoor and leisure, home accessories and lighting items will be included in the sales
Read more »

How Leeds-based COVVI is designing and producing a world leading bionic handHow Leeds-based COVVI is designing and producing a world leading bionic handAs a top paralympic swimmer, Jessica Smith has a passion for destroying barriers that others might find insurmountable
Read more »

Prevalence of sleep-related problems and risks in a community-dwelling older adult population: a cross-sectional survey-based study - BMC Public HealthPrevalence of sleep-related problems and risks in a community-dwelling older adult population: a cross-sectional survey-based study - BMC Public HealthBackground Despite evidence of adverse health consequences of inadequate restorative sleep for older adults, assessment of sleep quantity, quality, and use of sleep aids is not routinely done. We aimed to characterize sleep problems, sleep risks, and advice received about sleep in a community-dwelling older adult population, overall and in subgroups with health conditions and functional difficulties. Methods This cross-sectional study used weighted self-report data for 5074 Kaiser Permanente Northern California members aged 65-79y who responded to a 2017 or 2020 Member Health Survey. We estimated usual amount of sleep ( 20% reported discussing diet and exercise. Conclusions Large percentages of older adults experience sleep problems or get less sleep than recommended for optimal sleep health. Older patients should routinely be assessed on multiple components of sleep health (sleep hygiene, quantity, quality, problems, and sleep aid use) and educated about sleep hygiene and the importance of getting adequate restorative sleep for their overall health and wellbeing.
Read more »

Risk factors for natural menopause before the age of 45: evidence from two British population-based birth cohort studies - BMC Women's HealthRisk factors for natural menopause before the age of 45: evidence from two British population-based birth cohort studies - BMC Women's HealthBackground Menopause that occurs before the age of 45 and is not medically induced (referred to here as ‘early natural menopause’) affects around one in 10 women and has serious health consequences. These consequences include increased risk of all-cause mortality, cardiovascular disease, osteoporosis, and type 2 diabetes. Methods We investigate risk factors for the onset of natural menopause before the age of 45 in two population-based prospective cohort studies in Britain: the 1958 cohort following 8959 women and the 1970 cohort following 8655 women. These studies follow women from birth to adulthood, and we use harmonized data on birth and early life characteristics, reproductive health, health behaviour, and socioeconomic characteristics for 6805 women who were pre-menopausal, peri-menopausal or had undergone natural menopause. Of these 6805 women, 3614 participated in the 1958 cohort (of which 368 had early menopause) and 3191 participated in the 1970 cohort (of which 206 had early menopause). Taking a life course approach, we focus on three distinct life stages - birth/early life, childhood, and early adulthood - to understand when risk factors are most harmful. Respecting the temporal sequence of exposures, we use a series of multivariable logistic regression models to estimate associations between early menopause and each potential risk factor adjusted for confounders. Results We find that early menopause is influenced by circumstances at birth. Women born in lower social class families, whose mother smoked during the pregnancy or who were breastfed 1 month or less were more likely to undergo early menopause. Early menopause is also associated with poorer cognitive ability and smoking in childhood. Adult health behaviour also matters. Smoking is positively correlated with early menopause, while regular exercise and moderate frequency of alcohol drinking in women’s early thirties are associated with reduced risk of early menopause. The occurrence of gynaecolog
Read more »

Longitudinal multi-omics analysis identifies early blood-based predictors of anti-TNF therapy response in inflammatory bowel disease - Genome MedicineLongitudinal multi-omics analysis identifies early blood-based predictors of anti-TNF therapy response in inflammatory bowel disease - Genome MedicineBackground and aims Treatment with tumor necrosis factor α (TNFα) antagonists in IBD patients suffers from primary non-response rates of up to 40%. Biomarkers for early prediction of therapy success are missing. We investigated the dynamics of gene expression and DNA methylation in blood samples of IBD patients treated with the TNF antagonist infliximab and analyzed the predictive potential regarding therapy outcome. Methods We performed a longitudinal, blood-based multi-omics study in two prospective IBD patient cohorts receiving first-time infliximab therapy (discovery: 14 patients, replication: 23 patients). Samples were collected at up to 7 time points (from baseline to 14 weeks after therapy induction). RNA-sequencing and genome-wide DNA methylation data were analyzed and correlated with clinical remission at week 14 as a primary endpoint. Results We found no consistent ex ante predictive signature across the two cohorts. Longitudinally upregulated transcripts in the non-remitter group comprised TH2- and eosinophil-related genes including ALOX15, FCER1A, and OLIG2. Network construction identified transcript modules that were coherently expressed at baseline and in non-remitting patients but were disrupted at early time points in remitting patients. These modules reflected processes such as interferon signaling, erythropoiesis, and platelet aggregation. DNA methylation analysis identified remission-specific temporal changes, which partially overlapped with transcriptomic signals. Machine learning approaches identified features from differentially expressed genes cis-linked to DNA methylation changes at week 2 as a robust predictor of therapy outcome at week 14, which was validated in a publicly available dataset of 20 infliximab-treated CD patients. Conclusions Integrative multi-omics analysis reveals early shifts of gene expression and DNA methylation as predictors for efficient response to anti-TNF treatment. Lack of such signatures might be used to identify p
Read more »



Render Time: 2025-03-01 04:26:14